CJ CheilJedang Corp (CJ CheilJedang) is a global food and biotechnology company. Its product portfolio comprises home meal replacement, meat, fishery processing, seasoning, sauce, health food, ginseng beverages, sweeteners, flour, oil, seaweed, dessert, and snacks.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The R&D arm of CJ CheilJedang focuses on advancing food and bio research through its CJ Blossom Park, the largest research institute of its kind in Korea. This facility integrates all core food and bio research activities, creating synergy in research and commercialization, and facilitating the global expansion of K-Food. The company strives to bring about innovation in food processing technology, with a focus on health, convenience, and Korean food presentation. It also intends to develop future food resources and improve meat and marine product texture control, among other advanced processing technologies. The company focuses on the development of high-quality, health-conscious, and convenient food products, using innovative packaging to ensure taste and freshness. It strives to lead trends with its Home Meal Replacement (HMR) offerings, setting new standards in the food industry. The company strives to optimize production processes, from fermentation to purification, and incorporates real-time monitoring and smart factory technologies. It also focuses on developing biodegradable materials and bio-based chemicals, with a focus on sustainable and eco-friendly solutions in its bio research initiatives. In FY2024, the company incurred expenses of KRW43,295.2 million on R&D, which as a percentage of revenue stood at 0.1%.